Dose Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of GSK2849330 in Subjects With Advanced Her3-Positive Solid Tumors
Clinical trial NCT01966445 · COMPLETED
Trial details
- NCT number
- NCT01966445
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-26
- Primary completion
- 2017-09-18
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.